Dr. Vasiliki Fragkou is Thyrolytics new CTO, Nov 2019

By juni 28, 2020 juli 5th, 2020 No Comments

Dr. Vasiliki Fragkou brings 16 years of experience within In Vitro Diagnostics as well as experience in Science, Engineering, Quality, Regulatory, R&D and product Design and Development cycle. Further, she has experienced of ISO13485:2016 and In Vitro Device Regulation and has led the development of lateral flow and electrochemical enzyme / antibody based assays. She has also helped with product launches to enable them to enter CE and cFDA markets.

Leave a Reply